BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 35418058)

  • 1. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
    Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
    BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP14 expression levels accurately predict the presence of extranodal extensions in oral squamous cell carcinoma: a retrospective cohort study.
    Noda Y; Ishida M; Yamaka R; Ueno Y; Sakagami T; Fujisawa T; Iwai H; Tsuta K
    BMC Cancer; 2023 Feb; 23(1):142. PubMed ID: 36765296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
    Ahuja S; Khan AA; Zaheer S; Ranga S
    Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma.
    Kligerman MP; Moon PK; Tusty M; Cloutier JM; Ma Y; Holsinger CF; Divi V
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):731-737. PubMed ID: 35899590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological tumor thickness as a clinical predictor of pathological depth of invasion in oral squamous cell carcinoma: a retrospective analysis.
    Majumdar KS; Kaul P; Kailey VS; Maharaj DD; Thaduri A; Ilahi I; Panuganti A; Usmani SA; Singh A; Poonia DR; Singh MP; Bahurupi Y; Singh A; Agarwal SP; Sharma P; Seenivasagam RK
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1417-1423. PubMed ID: 36222926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of Extranodal Extension in Oral Cavity Squamous Cell Carcinoma is Not Independently Associated With Overall or Disease-Free Survival at a 2.0-mm Threshold.
    Best DL; Jazayeri HE; McHugh JB; Udager AM; Troost JP; Powell C; Moe J
    J Oral Maxillofac Surg; 2022 Dec; 80(12):1978-1988. PubMed ID: 36179764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
    Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
    Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis.
    Wahbi HS; Manadili A
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4177-4183. PubMed ID: 36580000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
    Sakai T; Saito Y; Tateishi Y; Yamazawa S; Fukuoka O; Kobayashi K; Omura G; Akashi K; Yoshida M; Ando M; Ebihara Y; Yamasoba T
    Int J Clin Oncol; 2022 Dec; 27(12):1818-1827. PubMed ID: 36197545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
    Silva GVD; da Silva Dolens E; ParanaĆ­ba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
    J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction Formula for Pathological Depth of Invasion From Clinical Depth of Invasion in Tongue Squamous Cell Carcinoma (SCC) Stage I/II Cases.
    Hamada M; Ebihara Y; Yoshida S; Saito N; Enoki Y; Inoue H; Matsumura S; Nakahira M; Yasuda M; Sugasawa M
    Cureus; 2023 Feb; 15(2):e34516. PubMed ID: 36879709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroscopic Extranodal Extension In Oral Squamous Cell Carcinoma-A Subgroup With Poor Survival.
    Joshi K; Agarwal M; Pasricha S; Singh A; Garg S; Rai S; Tandon S
    Laryngoscope; 2023 Mar; 133(3):588-593. PubMed ID: 35567419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma.
    Yavuz A; Simsek K; Alpsoy A; Altunay B; Gedik EO; Unal B; Bassorgun CI; Tatli AM; Elpek GO
    World J Gastrointest Pathophysiol; 2024 Apr; 15(1):91237. PubMed ID: 38682027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can morphological features evaluated in oral cancer biopsies influence in decision-making? A preliminary study.
    Leite CF; Silva KDD; Horta MCR; de Aguiar MCF
    Pathol Res Pract; 2020 Oct; 216(10):153138. PubMed ID: 32853958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the addition of extranodal extension and lymph node yield of pN0 to the lymph node ratio useful as a prognostic parameter for patients with oral squamous cell carcinoma?
    Yamagata K; Fukuzawa S; Uchida F; Okubo-Sato M; Ishibashi-Kanno N; Bukawa H
    Br J Oral Maxillofac Surg; 2021 Oct; 59(8):941-946. PubMed ID: 34456079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating ICOS
    Kajikawa H; Hirata M; Haruna M; Ueyama A; Hirose K; Kawashima A; Iwahori K; Matsunaga K; Toyosawa S; Uzawa N; Wada H
    Anticancer Res; 2022 May; 42(5):2383-2393. PubMed ID: 35489733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value and clinicopathological status of PD-L1 expression and CD8+ TILs in oral squamous cell cancer patients with or without traditional risk factors.
    Soopanit T; Laokulrath N; Chayopasakul V; Pongsapich W
    Head Neck; 2023 Apr; 45(4):1017-1025. PubMed ID: 36811208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension.
    Yokota Y; Hasegawa T; Yamakawa N; Rin S; Otsuru M; Yamada SI; Hirai E; Ashikaga Y; Yamamoto K; Ueda M; Kirita T; Umeda M; Akashi M; Kurita H; Ohiro Y; Yanamoto S; Okura M
    Oral Oncol; 2023 Oct; 145():106519. PubMed ID: 37459802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.